Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Clin Gastroenterol Hepatol

Retrieve available abstracts of 100 articles:
HTML format



Single Articles


    May 2020
  1. MELNYK J, Stefanov DG, Sultan K
    Inflammatory Bowel Disease and Corticosteroid induced Diabetes Mellitus.
    Clin Gastroenterol Hepatol. 2020 May 17. pii: S1542-3565(20)30678.
    PubMed    


  2. DULAI PS, Sandborn WJ, Murphy J
    Microsimulation Model to Determine the Cost Effectiveness of Treat to Target Strategies for Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 May 10. pii: S1542-3565(20)30644.
    PubMed     Abstract available


  3. CHENG D, Cushing KC, Cai T, Ananthakrishnan AN, et al
    Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.
    Clin Gastroenterol Hepatol. 2020 May 1. pii: S1542-3565(20)30615.
    PubMed     Abstract available


  4. FOTEINOGIANNOPOULOU K, Orfanoudaki E, Koutroubakis IE
    Keeping on the high quality of healthcare in Greek Inflammatory Bowel Disease patients in the SARS-CoV-2 era.
    Clin Gastroenterol Hepatol. 2020 May 1. pii: S1542-3565(20)30621.
    PubMed    


    April 2020
  5. ALLOCCA M, Fiorino G, Zallot C, Furfaro F, et al
    Incidence and patterns of COVID-19 among inflammatory bowel disease patients from the Nancy and Milan cohorts.
    Clin Gastroenterol Hepatol. 2020 Apr 30. pii: S1542-3565(20)30616.
    PubMed    


  6. EL-MATARY W, Guthery SL, Amir AZ, DiGuglielmo M, et al
    Colorectal Dysplasia and Cancer in Pediatric-onset Ulcerative Colitis Associated with Primary Sclerosing Cholangitis.
    Clin Gastroenterol Hepatol. 2020 Apr 29. pii: S1542-3565(20)30600.
    PubMed    


  7. BATTAT R, Hemperly A, Truong S, Whitmire N, et al
    Baseline Clearance of Infliximab is Associated with Requirement for Colectomy in Patients with Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Apr 26. pii: S1542-3565(20)30530.
    PubMed     Abstract available


  8. HANZEL J, Ma C, Marshall JK, Feagan BG, et al
    Managing Inflammatory Bowel Disease During COVID-19: Summary of Recommendations from Gastrointestinal Societies.
    Clin Gastroenterol Hepatol. 2020 Apr 21. pii: S1542-3565(20)30529.
    PubMed    


  9. ALLOCCA M, Fiorino G, Furfaro F, Gilardi D, et al
    Maintaining the quality standards of care for inflammatory bowel disease patients during the COVID-19 pandemic.
    Clin Gastroenterol Hepatol. 2020 Apr 15. pii: S1542-3565(20)30524.
    PubMed    


  10. LAI SW, Kuo YH, Liao KF
    Association Between Inflammatory Bowel Disease and Diabetes Mellitus.
    Clin Gastroenterol Hepatol. 2020;18:1002-1003.
    PubMed    


    March 2020
  11. MUIR AJ
    What Clues Can We Use From Primary Sclerosing Cholangitis With Inflammatory Bowel Disease Phenotypes?
    Clin Gastroenterol Hepatol. 2020 Mar 30. pii: S1542-3565(20)30430.
    PubMed    


  12. PAPAMICHAEL K, Clarke WT, Casteele NV, Germansky KA, et al
    Comparison between assays used for therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2020 Mar 5. pii: S1542-3565(20)30273.
    PubMed    


    February 2020
  13. NITTALA R, Singh A
    Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients with Active Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Feb 25. pii: S1542-3565(20)30208.
    PubMed    


  14. SONNENBERG A, Turner KO, Genta RM
    Comorbid Occurrence of Eosinophilic Esophagitis and Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30183.
    PubMed    


  15. LEVINE A, Rhodes JM, Lindsay JO, Abreu MT, et al
    Dietary Guidance for Patients with Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30185.
    PubMed     Abstract available


  16. KWAPISZ L, Raffals LE, Bruining DH, Pardi DS, et al
    Combination Biologic Therapy in Inflammatory Bowel Disease: Experience from a Tertiary Care Center.
    Clin Gastroenterol Hepatol. 2020 Feb 14. pii: S1542-3565(20)30186.
    PubMed    


  17. DULAI PS, Singh S, Casteele NV, Meserve J, et al
    Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Feb 13. pii: S1542-3565(20)30174.
    PubMed     Abstract available


    January 2020
  18. MAGRO F, Estevinho MM
    Do Neutrophils Contribute to Development of Crohn's Disease and Ulcerative Colitis?"
    Clin Gastroenterol Hepatol. 2020 Jan 30. pii: S1542-3565(20)30111.
    PubMed    


  19. LORES T, Goess C, Mikocka-Walus A, Collins KL, et al
    Integrated Psychological Care Reduces Healthcare Costs at a Hospital-Based Inflammatory Bowel Disease Service.
    Clin Gastroenterol Hepatol. 2020 Jan 30. pii: S1542-3565(20)30109.
    PubMed     Abstract available


  20. MA C, Smith M, Guizzetti L, Panaccione R, et al
    Assessing National Trends and Disparities in Ambulatory, Emergency Department, and Inpatient Visits for Inflammatory Bowel Disease in the United States (2005-2016).
    Clin Gastroenterol Hepatol. 2020 Jan 24. pii: S1542-3565(20)30102.
    PubMed     Abstract available


  21. DANESE S, Fiorino G, Peyrin-Biroulet L
    Positioning therapies in ulcerative colitis.
    Clin Gastroenterol Hepatol. 2020 Jan 23. pii: S1542-3565(20)30096.
    PubMed     Abstract available


  22. SINGH S, Murad MH, Fumery M, Dulai PS, et al
    First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis.
    Clin Gastroenterol Hepatol. 2020 Jan 13. pii: S1542-3565(20)30044.
    PubMed     Abstract available


  23. LE BAUT G, Kirchgesner J, Amiot A, Lefevre JH, et al
    A Scoring System to Determine Patients' Risk of Colectomy Within 1 y After Hospital Admission for Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Jan 9. pii: S1542-3565(20)30029.
    PubMed     Abstract available


  24. KAUR M, Dalal RL, Shaffer S, Schwartz DA, et al
    Inpatient Management of Inflammatory Bowel Disease Related Complications.
    Clin Gastroenterol Hepatol. 2020 Jan 9. pii: S1542-3565(20)30034.
    PubMed     Abstract available


  25. DANESE S, Neurath MF, Kopon A, Zakko SF, et al
    Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2020 Jan 8. pii: S1542-3565(20)30005.
    PubMed     Abstract available


    December 2019
  26. HIRTEN RP, Lakatos PL, Halfvarson J, Colombel JF, et al
    A Users Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Dec 27. pii: S1542-3565(19)31499.
    PubMed     Abstract available


  27. SIEGEL CA, Thompson KD, Walls D, Gollins J, et al
    Crohn's disease patients' and gastroenterologists' perspectives towards de-escalating inflammatory bowel disease therapy.
    Clin Gastroenterol Hepatol. 2019 Dec 27. pii: S1542-3565(19)31498.
    PubMed    


  28. PAI RK, Hartman DJ, Rivers CR, Regueiro M, et al
    Complete Resolution of Mucosal Neutrophils Associates With Improved Long-Term Clinical Outcomes of Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Dec 13. pii: S1542-3565(19)31438.
    PubMed     Abstract available


  29. ADEDOKUN OJ, Xu Z, Marano C, O'Brien C, et al
    Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative Colitis: Ustekinumab PK and exposure-response in UC.
    Clin Gastroenterol Hepatol. 2019 Dec 6. pii: S1542-3565(19)31403.
    PubMed     Abstract available


  30. LAI SW
    Herpes Zoster Vaccine in Older Adults With Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:2823.
    PubMed    


    November 2019
  31. BERGQUIST A, Stokkeland K, Bottai M, Soderberg-Lofdal K, et al
    Reply - Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2019 Nov 12. pii: S1542-3565(19)31276.
    PubMed    


    October 2019
  32. VILLUMSEN M, Jess T, Allin KH
    Association between inflammatory bowel disease and diabetes mellitus - study population matters.
    Clin Gastroenterol Hepatol. 2019 Oct 10. pii: S1542-3565(19)31104.
    PubMed    


  33. FUNG BM, Ali AH, Tabibian JH
    Associations between drug exposure and outcomes in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2019 Oct 5. pii: S1542-3565(19)31095.
    PubMed    


  34. BARNES EL, Lightner AL, Regueiro M
    Peri-operative and Post-operative Management of Patients with Crohn's Disease and Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Oct 4. pii: S1542-3565(19)31091.
    PubMed     Abstract available


    September 2019
  35. MA C, Sandborn WJ, D'Haens GR, Zou G, et al
    Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Sep 20. pii: S1542-3565(19)31027.
    PubMed     Abstract available


  36. CASAVANT E, Park KT, Elias JE
    Proteomic discovery of stool protein biomarkers for distinguishing pediatric inflammatory bowel disease flares.
    Clin Gastroenterol Hepatol. 2019 Sep 6. pii: S1542-3565(19)30974.
    PubMed    


    August 2019
  37. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Use of narrative concepts in the EHR to validate genetic determinants of treatment response in a virtual inflammatory bowel disease cohort.
    Clin Gastroenterol Hepatol. 2019 Aug 9. pii: S1542-3565(19)30861.
    PubMed    


  38. O'CONNOR A, Gracie DJ, Hamlin PJ, Ford AC, et al
    Letter: Predictors of Dyspareunia Among Female Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Aug 8. pii: S1542-3565(19)30854.
    PubMed    


  39. NAGANUMA M, Kobayashi T, Nasuno M, Motoya S, et al
    Significance of Conducting 2 Types of Fecal Tests in Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30843.
    PubMed     Abstract available


  40. JESS T, Jensen BW, Andersson M, Villumsen M, et al
    Inflammatory Bowel Disease Increases Risk of Type 2 Diabetes in a Nationwide Cohort Study.
    Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30841.
    PubMed     Abstract available


  41. REINISCH W, Gottlieb K, Colombel JF, Danese S, et al
    Comparison of the EMA and FDA Guidelines on Ulcerative Colitis Drug Development.
    Clin Gastroenterol Hepatol. 2019;17:1673-1679.
    PubMed     Abstract available


    July 2019
  42. LICHTENSTEIN GR, Shahabi A, Seabury SA, Lakdawalla DN, et al
    Lifetime Economic Burden of Crohn's Disease and Ulcerative Colitis by Age at Diagnosis.
    Clin Gastroenterol Hepatol. 2019 Jul 18. pii: S1542-3565(19)30765.
    PubMed     Abstract available


  43. LE BERRE C, Ananthakrishnan AN, Danese S, Singh S, et al
    Ulcerative Colitis and Crohn's Disease Have the Same Burden and Goals for Treatment.
    Clin Gastroenterol Hepatol. 2019 Jul 10. pii: S1542-3565(19)30738.
    PubMed     Abstract available


  44. KISIEL JB, Mahoney DW, Taylor WR, Klepp P, et al
    Response to: Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients (CGH-D-19-01071).
    Clin Gastroenterol Hepatol. 2019 Jul 4. pii: S1542-3565(19)30729.
    PubMed    


    June 2019
  45. ISRAEL A, Christensen B, El Jurdi K, Rai V, et al
    Follow-Up of Ulcerative Colitis Patients Who Have Achieved Histological Normalization.
    Clin Gastroenterol Hepatol. 2019 Jun 19. pii: S1542-3565(19)30663.
    PubMed    


  46. LAM SY, Yu J, Peppelenbosch MP
    Value of VAV3 methylation in stool DNA might be restricted to non-thiopurine treated inflammatory bowel disease patients.
    Clin Gastroenterol Hepatol. 2019 Jun 17. pii: S1542-3565(19)30658.
    PubMed    


  47. KHALILI H
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:1418-1419.
    PubMed    


  48. YANG XY, Chen PF, He JH
    High Consumption of Sweetened Beverages Might Increase the Risk of Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:1417-1418.
    PubMed    


    May 2019
  49. SINGH S, Proudfoot JA, Dulai PS, Xu R, et al
    Efficacy and Speed of Induction of Remission of Infliximab vs Golimumab for Patients With Ulcerative Colitis, Based on Data From Clinical Trials.
    Clin Gastroenterol Hepatol. 2019 May 17. pii: S1542-3565(19)30529.
    PubMed     Abstract available


  50. KIRCHGESNER J, Svrcek M, Le Gall G, Landman C, et al
    Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.
    Clin Gastroenterol Hepatol. 2019 May 11. pii: S1542-3565(19)30511.
    PubMed     Abstract available


  51. SANDS BE, Taub PR, Armuzzi A, Friedman GS, et al
    Tofacitinib Treatment is Associated with Modest and Reversible Increases in Serum Lipids in Patients with Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 May 8. pii: S1542-3565(19)30491.
    PubMed     Abstract available


  52. GRILLER N, Cohen L
    Rapid Onset of Tofacitinib Induction Therapy for the Treatment of Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019;17:1213.
    PubMed    


  53. FRAGAKI M, Demetriou G, Koutroubakis IE
    Risk Factors of Colectomy in Patients With Refractory Ulcerative Colitis Under Calcineurin Inhibitors Combined With Vedolizumab.
    Clin Gastroenterol Hepatol. 2019;17:1213-1214.
    PubMed    


  54. LAHARIE D, Pellet G
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:1214-1215.
    PubMed    


    April 2019
  55. UNO Y
    Risk of Probiotics: Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Apr 17. pii: S1542-3565(19)30421.
    PubMed    


  56. WEINTRAUB Y, Cohen S, Chapnik N, Ben-Tov A, et al
    Clock Gene Disruption is an Initial Manifestation of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30373.
    PubMed     Abstract available


  57. ANANTHAKRISHNAN AN
    Reply to letter to the editor: Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Apr 6. pii: S1542-3565(19)30365.
    PubMed    


    March 2019
  58. DAI C, Jiang M, Huang YH
    Effect of Accelerated Infliximab Induction on Outcomes of Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Mar 27. pii: S1542-3565(19)30298.
    PubMed    


  59. EGBERG MD, Galanko JA, Kappelman MD
    Patients Who Undergo Colectomy for Pediatric Ulcerative Colitis at Low-volume Hospitals Have More Complications.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30251.
    PubMed     Abstract available


  60. KHAN N, Lee H, Trivedi C, Kavani H, et al
    Mortality Associated With Development of Squamous Cell Cancer in Patients With Inflammatory Bowel Disease Receiving Treatment With Thiopurines.
    Clin Gastroenterol Hepatol. 2019 Mar 7. pii: S1542-3565(19)30254.
    PubMed     Abstract available


  61. ZANOLI L
    Increased Cardiovascular Risk in Patients With Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:799-800.
    PubMed    


  62. ANIWAN S, Loftus EV Jr
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:800-801.
    PubMed    


  63. HIRTEN RP, Ghosh S, Colombel JF
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:796-797.
    PubMed    


  64. LE BERRE C, Loeuille D, Peyrin-Biroulet L
    Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy.
    Clin Gastroenterol Hepatol. 2019;17:794-796.
    PubMed    


    February 2019
  65. BURISCH J, Jess T
    Does eradication of Helicobacter pylori cause inflammatory bowel disease?
    Clin Gastroenterol Hepatol. 2019 Feb 12. pii: S1542-3565(19)30153.
    PubMed    


  66. GRACIE DJ, Ford AC
    Functional Gastrointestinal Symptoms in Inflammatory Bowel Disease: Rising to the Challenge.
    Clin Gastroenterol Hepatol. 2019;17:572-573.
    PubMed    


  67. MINER PB JR
    Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019 Feb 1. pii: S1542-3565(19)30137.
    PubMed    


  68. JOHNSON C, Binion DG
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:576.
    PubMed    


  69. COLOMBEL JF, Shin A, Gibson PR
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:573-574.
    PubMed    


  70. PARDI DS, Cotter TG, Loftus EV Jr
    Reply.
    Clin Gastroenterol Hepatol. 2019;17:572.
    PubMed    


  71. DULAI PS, Peyrin-Biroulet L
    Integrating Patient-Reported Outcomes Into Treat-to-Target Monitoring Algorithms.
    Clin Gastroenterol Hepatol. 2019;17:395-396.
    PubMed    


  72. VAN KRUININGEN HJ, Sura R
    Erroneous Use of Endoscopic Biopsy Data in Crohn's Disease.
    Clin Gastroenterol Hepatol. 2019;17:575-576.
    PubMed    


  73. MACALUSO FS, Cottone M, Orlando A
    Risk of Pneumonia Caused by Pneumocystis jiroveci in Inflammatory Bowel Disease: The Role of Concomitant Pulmonary Comorbidities.
    Clin Gastroenterol Hepatol. 2019;17:571-572.
    PubMed    


  74. COLOMBEL JF, Shin A, Gibson PR
    AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review.
    Clin Gastroenterol Hepatol. 2019;17:380-390.
    PubMed     Abstract available


  75. BEAUGERIE L, Kirchgesner J
    Balancing Benefit vs Risk of Immunosuppressive Therapy for Individual Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:370-379.
    PubMed     Abstract available


  76. NALAGATLA N, Falloon K, Tran G, Borren NZ, et al
    Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis.
    Clin Gastroenterol Hepatol. 2019;17:502-509.
    PubMed     Abstract available


  77. NARULA N, Alshahrani AA, Yuan Y, Reinisch W, et al
    Patient-Reported Outcomes and Endoscopic Appearance of Ulcerative Colitis: A Systematic Review and Meta-analysis.
    Clin Gastroenterol Hepatol. 2019;17:411-418.
    PubMed     Abstract available


  78. SIMSEK M, Meijer B, Ramsoekh D, Bouma G, et al
    Clinical Course of Nodular Regenerative Hyperplasia in Thiopurine Treated Inflammatory Bowel Disease Patients.
    Clin Gastroenterol Hepatol. 2019;17:568-570.
    PubMed     Abstract available


  79. CHRISTENSEN B, Gibson PR, Micic D, Colman RJ, et al
    Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2019;17:486-493.
    PubMed     Abstract available


    January 2019
  80. FALECK DM, Winters A, Chablaney S, Shashi P, et al
    Shorter Disease Duration is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease but Not Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019 Jan 5. pii: S1542-3565(19)30013.
    PubMed     Abstract available


  81. HANAUER S, Panaccione R, Danese S, Cheifetz A, et al
    Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019;17:139-147.
    PubMed     Abstract available


  82. FEAGAN BG, Lasch K, Lissoos T, Cao C, et al
    Rapid Response to Vedolizumab Therapy in Biologic-Naive Patients With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:130-138.
    PubMed     Abstract available


  83. KHALILI H, Hakansson N, Chan SS, Ludvigsson JF, et al
    No Association Between Consumption of Sweetened Beverages and Risk of Later-Onset Crohn's Disease or Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2019;17:123-129.
    PubMed     Abstract available


  84. KRUIS W, Neshta V, Pesegova M, Alekseeva O, et al
    Budesonide Suppositories Are Effective and Safe for Treating Acute Ulcerative Proctitis.
    Clin Gastroenterol Hepatol. 2019;17:98-106.
    PubMed     Abstract available


  85. ANANTHAKRISHNAN AN, Martin C, Kane S, Sandler RS, et al
    Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases.
    Clin Gastroenterol Hepatol. 2019;17:203-204.
    PubMed     Abstract available


    December 2018
  86. RESTELLINI S, Chao CY, Martel M, Barkun A, et al
    Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis-a Systematic Review.
    Clin Gastroenterol Hepatol. 2018 Dec 21. pii: S1542-3565(18)31397.
    PubMed     Abstract available


  87. MA C, Kotze PG, Almutairdi A, Jairath V, et al
    Concomitant Use of Aminosalicylates Is Not Associated with Improved Outcomes in Patients with Ulcerative Colitis Escalated to Vedolizumab.
    Clin Gastroenterol Hepatol. 2018 Dec 7. pii: S1542-3565(18)31341.
    PubMed    


  88. WEAVER KN, Long MD
    Preventive Medicine in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Dec 6. pii: S1542-3565(18)31331.
    PubMed     Abstract available


    November 2018
  89. SANDBORN WJ, Panes J, D'Haens GR, Sands BE, et al
    Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials.
    Clin Gastroenterol Hepatol. 2018 Nov 23. pii: S1542-3565(18)31278.
    PubMed     Abstract available


  90. BERINSTEIN JA, Steiner CA, Regal RE, Allen JI, et al
    Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Nov 17. pii: S1542-3565(18)31265.
    PubMed    


  91. TARGOWNIK LE, Benchimol EI, Bernstein CN, Singh H, et al
    Upfront Combination Therapy, Compared with Monotherapy, for Patients Not Previously Treated with a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31246.
    PubMed     Abstract available


    October 2018
  92. AXELRAD JE, Olen O, Askling J, Lebwohl B, et al
    Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study.
    Clin Gastroenterol Hepatol. 2018 Oct 30. pii: S1542-3565(18)31025.
    PubMed     Abstract available


  93. VANDE CASTEELE N, Jeyarajah J, Jairath V, Feagan BG, et al
    Infliximab Exposure-Response Relationship and Thresholds Associated with Endoscopic Healing in Patients With Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Oct 26. pii: S1542-3565(18)31200.
    PubMed     Abstract available


  94. DAI C, Jiang M, Sun MJ
    The Association Between Consumption of Sweetened Beverages and the Risk of Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018;16:1681-1682.
    PubMed    


  95. GOLDSMITH JR, Sartor RB
    Opioid Toxicity in Inflammatory Bowel Disease Patients Likely Includes Direct Enterocyte Effects That Exacerbate Disease.
    Clin Gastroenterol Hepatol. 2018;16:1679-1680.
    PubMed    


    September 2018
  96. HART AL, Bouri S
    Onset of action of Inflammatory Bowel Disease medications: how quickly do they really work?
    Clin Gastroenterol Hepatol. 2018 Sep 19. pii: S1542-3565(18)31012.
    PubMed    


  97. MORILLA I, Uzzan M, Laharie D, Cazals-Hatem D, et al
    Colonic microRNA Profiles, Identified by a Deep-learning Algorithm, That Predict Responses of Patients With Acute Severe Ulcerative Colitis to Therapy.
    Clin Gastroenterol Hepatol. 2018 Sep 14. pii: S1542-3565(18)30947.
    PubMed     Abstract available


  98. PELLET G, Stefanescu C, Carbonnel F, Peyrin-Biroulet L, et al
    Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination with Vedolizumab in Patients With Refractory Ulcerative Colitis.
    Clin Gastroenterol Hepatol. 2018 Sep 10. pii: S1542-3565(18)30966.
    PubMed     Abstract available


  99. RAFFALS LE, Nguyen GC, Rubin DT, Nguyen GC, et al
    Switching Between Biologics and Biosimilars in Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30943.
    PubMed    


  100. SOMINENI HK, Kugathasan S
    The microbiome in inflammatory bowel disease: from prevailing clinical evidence to future possibilities.
    Clin Gastroenterol Hepatol. 2018 Sep 6. pii: S1542-3565(18)30957.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: